Generated by DeepSeek V3.2| pinta | |
|---|---|
| Name | Pinta |
| Field | Dermatology, Infectious disease |
| Symptoms | Skin lesions, dyschromia |
| Causes | Treponema carateum |
| Diagnosis | Clinical, Dark-field microscopy |
| Treatment | Penicillin |
| Prevention | Public health measures |
pinta. Pinta is a chronic, non-venereal treponemal infection caused by the spirochete bacterium Treponema carateum. It is one of the so-called endemic treponematoses, a group that also includes Yaws and Bejel. The disease is characterized primarily by skin manifestations, leading to significant discoloration and depigmentation, but does not involve the cardiovascular or neurological systems like Syphilis.
Pinta, also known as **carate** or **mal del pinto**, is the most benign of the human treponematoses, affecting only the skin. The disease is historically significant in the Americas, with evidence suggesting its presence prior to European contact. It shares a close phylogenetic relationship with the causative agents of Yaws and Bejel, as determined by genetic studies. Unlike its more severe relative Syphilis, pinta does not cause destructive lesions of bone or cartilage and is not transmitted congenitally. The primary public health concern revolves around the disfiguring skin changes that can lead to social stigma.
The etiological agent of pinta is the spiral-shaped bacterium Treponema carateum. This organism is morphologically and serologically indistinguishable from Treponema pallidum, the cause of Syphilis, but is genetically distinct. Transmission occurs through direct, non-sexual skin-to-skin contact with infectious lesions, typically among children and young adults living in crowded conditions with poor hygiene. The bacteria enter the body through minor abrasions in the skin. Certain vectors, such as flies, have been hypothesized to play a role in mechanical transmission, but this is not definitively proven. The disease is not considered sexually transmitted.
The clinical course of pinta progresses through distinct stages. The **primary lesion** appears at the site of inoculation after an incubation period of one to three weeks, starting as a small papule that slowly enlarges into a scaly, erythematous plaque, often on exposed areas like the legs, arms, or face. Several months later, **secondary lesions**, known as "pintids," erupt diffusely. These are similar to the primary lesion but more numerous and can vary in color from red to violet. The final, **tertiary or late phase**, involves profound dyschromia, where lesions become hypopigmented (white), hyperpigmented (blue, slate-gray), or achromic. This stage is marked by a characteristic "leopard skin" appearance, with no associated systemic symptoms.
Diagnosis is primarily based on **clinical presentation** and **epidemiological context** in endemic regions. Dark-field microscopy of exudate from early moist lesions can reveal the characteristic motile spirochetes. Serological tests for treponemal infections, such as the Treponema pallidum particle agglutination (TPPA) assay or the Fluorescent treponemal antibody absorption (FTA-ABS) test, are reactive but cannot differentiate pinta from other treponematoses like Syphilis or Yaws. Non-treponemal tests like the Rapid plasma reagin (RPR) or Venereal Disease Research Laboratory (VDRL) test are often non-reactive, especially in late stages. Biopsy of a lesion may show typical histopathological findings.
The treatment of choice is a single intramuscular injection of **long-acting Penicillin**, specifically Benzathine benzylpenicillin. This is highly effective in curing the infection and preventing further transmission, though it may not reverse established skin discoloration. For patients allergic to penicillin, alternatives like Tetracycline or Erythromycin can be administered. Prevention relies on **public health measures** aimed at early diagnosis, treatment of cases and contacts, and improving living conditions. Mass drug administration campaigns, similar to those used against Yaws by the World Health Organization, have been historically successful in reducing prevalence in endemic foci.
Pinta was once endemic in remote, rural, and impoverished communities of tropical Latin America, including areas of Mexico, Colombia, Peru, Brazil, and Cuba. Its prevalence has declined dramatically since the mid-20th century due to widespread Penicillin use and public health initiatives. Today, it is considered extremely rare and possibly eradicated, with the last confirmed cases reported decades ago from isolated regions. However, some experts caution that sporadic cases may still occur in very remote populations. The disease predominantly affected children and adolescents, with no racial or sexual predilection. Category:Infectious diseases Category:Dermatology Category:Bacterial diseases